ArticleMolecular therapy. Methods & clinical development2024

Preclinical evaluation of NG101, a potential AAV gene therapy for wet age-related macular degeneration.

Juwon Shim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.